GlassScriptPhysician profile
Lindsay Wriston
NPI 1952531469
$708.10
in general payments reported to CMS, 2019-2025
18 companies · $398 in 2025
The $398 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.69 · 2022: $38.94 · 2023: $94.96 · 2024: $114 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $120.58 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $118.41 | 2023-2025 | Veozah |
| Minerva Surgical, INC | $95.70 | 2025 | |
| Intuitive Surgical, INC. | $46.14 | 2019 | |
| Coopersurgical, INC. | $38.21 | 2024-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $36.87 | 2023-2024 | |
| Pfizer INC. | $32.88 | 2023-2025 | |
| Exact Sciences Corporation | $29.63 | 2025 | Cologuard Collection Kit |
| Organon LLC | $28.53 | 2025 | Nexplanon |
| Daiichi Sankyo INC. | $21.56 | 2023 | Injectafer |
| Mayne Pharma Commercial LLC | $21.46 | 2023 | |
| Hologic Sales and Service, LLC | $19.45 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
| Abbvie INC. | $18.62 | 2022 | |
| Merck Sharp & Dohme LLC | $17.14 | 2024 | Gardasil, Gardasil 9 |
| Smith+Nephew, INC. | $16.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $16.53 | 2025 | Arista |
| Biogen, INC. | $14.97 | 2025 | Zurzuvae |
| Meditrina | $14.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Wriston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.